Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow cognitive decline.
from NYT > Health https://ift.tt/VSTz3oR
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment